Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Hum Reprod
; 37(5): 884-894, 2022 05 03.
Article
in En
| MEDLINE
| ID: mdl-35143669
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Neoplasms
/
Leiomyoma
/
Norpregnadienes
Type of study:
Clinical_trials
/
Guideline
Limits:
Female
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Hum Reprod
Journal subject:
MEDICINA REPRODUTIVA
Year:
2022
Type:
Article
Affiliation country:
Netherlands